Loading company…
Peptimmune develops biotechnology treatments for chronic autoimmune and metabolic disorders.
Peptimmune is a clinical-stage biotechnology company focused on chronic autoimmune and metabolic disorders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in